Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,000,000 2.700% |
-691,623 (-40.89%) |
Filing |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,691,623 5.200% |
34,000 (+2.05%) |
Filing |
| 2020-11-16 4:05 pm Purchase |
2020-11-06 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,657,623 5.100% |
1,657,623 (New Position) |
Filing |